Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto et al. · Kidney International · 2005 · 3.9K citations · Full text

Medicine, Internal Medicine, Nephrology +17

Markov Models in Medical Decision Making

Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations

Business, Decision Sciences, Clinical Decision Support +16

Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies

Milton C. Weinstein, John Hornberger, Magnus Johannesson et al. · Value in Health · 2003 · 1.2K citations · Full text

Public Affairs, Health Systems, Decision Analysis +9

Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy

Ming Teng, Myles Wolf, Edmund G. Lowrie et al. · New England Journal of Medicine · 2003 · 926 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature

Seán F. Dinneen · Archives of Internal Medicine · 1997 · 738 citations

Medicine, Endocrinology, Internal Medicine +13